CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice

Proceedings of the National Academy of Sciences of the United States of America
Terrence F Meehan, Hector F DeLuca

Abstract

In addition to its role in calcium and phosphorous homeostasis, 1 alpha,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] appears to be a modulator of the immune system. Administration of 1,25-(OH)(2)D(3) prevents disease in several autoimmune animal models, including experimental autoimmune encephalomyelitis (EAE). The vitamin D receptor is believed to mediate this activity. Among cells of the immune system, CD8(+) T cells have the highest levels of the vitamin D receptor. Because CD8(+) T cells have been implicated as both suppressors and effectors of the inflammation associated with multiple sclerosis and EAE, we examined the question of whether the 1,25-(OH)(2)D(3) suppression of EAE occurs through a CD8(+) T cell-dependent mechanism. To test this hypothesis, mice that are homozygous knockouts for the alpha chain of the CD8 receptor and have been characterized as lacking functional CD8(+) T cells (CD8(+) -/-) were provided 1,25-(OH)(2)D(3) in their diet before EAE induction. Although CD8(+) -/- mice fed the same diet lacking 1,25-(OH)(2)D(3) have a high incidence of EAE, EAE did not occur in CD8(+) -/- mice fed the diet containing 1,25-(OH)(2)D(3). We conclude that CD8(+) T cells neither are needed nor do they play a role in the ...Continue Reading

References

Mar 1, 1991·The Journal of Clinical Investigation·J M Lemire, D C Archer
Oct 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·D H MillerD C Skegg
Apr 1, 1989·The Journal of Clinical Endocrinology and Metabolism·D M Provvedini, S C Manolagas
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H ReichelA W Norman
May 19, 1973·Lancet·M Alter, M Morariu
Jan 1, 1967·Acta Neurologica Scandinavica·J F Kurtzke
Jun 29, 1984·Science·C D TsoukasS C Manolagas
Jun 1, 1995·Journal of Autoimmunity·A W LohseK H Meyer zum Büschenfelde
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M T CantornaH F DeLuca
Jan 1, 1996·Autoimmunity·J MonteiroP K Gregersen
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·M WillheimM Peterlik
Nov 11, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·L M MetzD McGowan
Nov 11, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·P Gallien, S Robineau
Feb 10, 2000·Archives of Biochemistry and Biophysics·C M VeldmanH F DeLuca
Apr 12, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·E Kahana
Apr 25, 2000·Biochemical and Biophysical Research Communications·M D GriffinR Kumar
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·H JiangL Chess
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D SunC S Raine
Sep 6, 2001·The Journal of Experimental Medicine·E S HusebyJ Goverman
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H F Deluca, M T Cantorna
Jan 1, 1960·Acta Psychiatrica Scandinavica. Supplementum·J PRESTHUS

❮ Previous
Next ❯

Citations

Aug 21, 2012·Calcified Tissue International·Marie B Demay
Apr 29, 2009·Journal of Neurology·Charles Pierrot-Deseilligny
Dec 22, 2004·The Journal of Experimental Medicine·Jerome J A HendriksHelga E de Vries
Mar 26, 2003·Annual Review of Nutrition·Matthew D GriffinRajiv Kumar
Aug 25, 2006·Journal of Neuroinflammation·Ana I EsquifinoDaniel P Cardinali
Aug 30, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Tom L Van BelleChantal Mathieu
May 6, 2014·Frontiers in Physiology·Rene F ChunMartin Hewison
Jan 7, 2014·The American Journal of Pathology·Andrew J McClellanCintia S de Paiva
May 15, 2013·Ophthalmology·Yukan HuangScheffer C G Tseng
Jan 8, 2008·Journal of Neuroimmunology·Joost SmoldersRaymond Hupperts
Sep 7, 2012·Journal of Child Neurology·David Vargas-Lowy, Tanuja Chitnis
Jul 26, 2008·Journal of Cellular Biochemistry·Anita RaghuwanshiSylvia Christakos
Feb 26, 2009·Experimental Dermatology·Ulrich ZügelKhusru Asadullah
Mar 31, 2005·Endocrine Reviews·Sunil NagpalRadhakrishnan Rathnachalam
Jun 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jan EhrchenAndreas Lengeling
Sep 8, 2011·Immunology·Michelino Di RosaLucia Malaguarnera
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karen M SpachColleen E Hayes
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karen M Spach, Colleen E Hayes
Aug 19, 2011·The Proceedings of the Nutrition Society·Martin Hewison
Feb 7, 2017·Frontiers in Immunology·Wendy DankersErik Lubberts
Sep 11, 2018·Periodontology 2000·Henrik DommischIain Chapple
Sep 13, 2018·International Journal of Molecular Sciences·Mayte MedranoJose A Perez-Simon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.